Last reviewed · How we verify
NCT02486835
Efficacy & Tolerability of a Specific Plantain,Thyme and Honey Cough Syrup vs Placebo in Child Cough Due to Common Cold
NA trial testing Cough syrup for adults and children in Cough in 150 participants. Completed in 6 April 2016.
3 April 2016
Quick facts
| Lead sponsor | Clalit Health Services |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 23 December 2015 |
| Primary completion | 3 April 2016 |
| Estimated completion | 6 April 2016 |
| Sites | 4 locations across Israel |
Drugs / interventions tested
- Cough syrup for adults and children
- Placebo
Conditions studied
- Cough — all drugs for Cough →
Sponsor
Clalit Health Services — full company profile →
Who can join
Adults 1 to 5, any sex, with Cough. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cough is a life saving reflex, therefore it is important, especially in pediatrics, to calm cough spells without sedating the reflex. The intent of this study is to use a protective syrup with does not act as a sedative or as a potent mucolytic and measure its efficacy and safety versus placebo in children with moderate to severe night and daily cough. Cough is assessed with a validated parent questionnaire. The degree of disturbance of cough is followed immediately after one night administration of the study products and daily for 4 nights, 3 days.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02486835
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cough
Currently open trials in the same condition.
- NCT07171099 — Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children · Phase 3 · recruiting
- NCT06999577 — The Mechanism Versus PPI Trial · Phase 4 · recruiting
- NCT06979141 — Dexmedetomidine, Magnesium Sulphate and Lidocaine for Cough Suppression After General Anesthesia · Phase 3 · recruiting
- NCT06918756 — Development of a Cough Control Questionnaire (CCQ) · recruiting
- NCT06878209 — Cough and Hemorrhoids · recruiting
Other Clalit Health Services trials
Trials by the same sponsor.
- NCT04709003 — Covid-19 Vaccine Effectiveness in Healthcare Personnel in Clalit Health Services in Israel (CoVEHPI) · completed
- NCT04228159 — Perturbation Training Compared to Balance and Strengthening Exercise, for Elderly at Risk of Falling · NA · unknown
- NCT03973658 — Dizziness Among First Time Users of Hearing Aids · unknown
- NCT03867019 — The Cardiac Autonomic Control System Response to Vestibular Stimulation in Subjects With and Without BPPV · completed
- NCT03821220 — Improving Physical Activity Levels in the Arabic- Speaking Residents of East Jerusalem With Prediabetes · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02486835 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clalit Health Services
- Last refreshed: 29 January 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02486835.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing